Premium
O2–03–03: Selective T1‐weighted enhancement of individual Alzheimer's disease amyloid plaques using an antibody fragment against Aβ42 as a magnetic resonance molecular imaging contrast agent
Author(s) -
Poduslo Joseph F.,
Ramakrishnan Muthu,
Wengenack Thomas M.,
Kandimalla Karunya K.,
Curran Geoffry L.,
Gilles Emily J.,
Ramirez-Alvarado Marina,
Garwood Michael,
Jack Clifford R.
Publication year - 2007
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2007.04.028
Subject(s) - in vivo , mri contrast agent , magnetic resonance imaging , gadolinium , chemistry , pathology , molecular imaging , pittsburgh compound b , amyloid (mycology) , alzheimer's disease , biophysics , medicine , biology , disease , microbiology and biotechnology , organic chemistry , radiology